Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$245M |
| 2 |
Procter & Gamble
PG
|
+$205M |
| 3 |
Coca-Cola
KO
|
+$129M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$128M |
| 5 |
Johnson & Johnson
JNJ
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$436M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$100M |
| 3 |
NetEase
NTES
|
+$26.7M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$25.5M |
| 5 |
Tesla
TSLA
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.66% |
| 2 | Consumer Discretionary | 13.07% |
| 3 | Healthcare | 9.52% |
| 4 | Technology | 3.33% |
| 5 | Financials | 3.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Texas Instruments
TXN
$261B
| $5.83M | 0.05% |
35,511
+21,185
| +148% | +$3.29M |
|
177
Texas Roadhouse
TXRH
$13.7B
| $5.81M | 0.05% |
74,365
+40,601
| +120% | +$3.02M |
|
178
Dentsply Sirona
XRAY
$2.43B
| $5.79M | 0.05% |
110,638
+55,770
| +102% | +$2.75M |
|
179
Ollie's Bargain Outlet
OLLI
$4.94B
| $5.75M | 0.05% |
70,274
+41,898
| +148% | +$3.66M |
|
180
Teladoc Health
TDOC
$1.3B
| $5.66M | 0.05% |
+28,317
| New | +$5.76M |
|
181
iShares MSCI South Korea ETF
EWY
$24.1B
| $5.65M | 0.05% |
65,695
-3,476
| -5% | -$257K |
|
182
S&P Global
SPGI
$120B
| $5.59M | 0.05% |
17,000
+3,739
| +28% | +$1.26M |
|
183
Paycom
PAYC
$10B
| $5.58M | 0.05% |
12,338
-10,522
| -46% | -$4.19M |
|
184
Emerson Electric
EMR
$88.3B
| $5.55M | 0.05% |
69,086
+24,680
| +56% | +$1.83M |
|
185
Martin Marietta Materials
MLM
$33B
| $5.55M | 0.05% |
19,549
-5,826
| -23% | -$1.55M |
|
|
AMED
186
DELISTED
Amedisys
AMED
| $5.53M | 0.05% |
18,838
+10,932
| +138% | +$2.8M |
|
187
iShares MSCI Brazil ETF
EWZ
$8.95B
| $5.45M | 0.05% |
147,111
-20,536
| -12% | -$662K |
|
188
Ingredion
INGR
$6.58B
| $5.39M | 0.05% |
68,544
+36,680
| +115% | +$2.83M |
|
|
ONC
189
BeOne Medicines Ltd
ONC
$38.7B
| $5.37M | 0.05% |
+20,799
| New | +$5.73M |
|
190
Delta Air Lines
DAL
$60.1B
| $5.35M | 0.05% |
+133,001
| New | +$4.84M |
|
191
Analog Devices
ADI
$190B
| $5.33M | 0.05% |
36,089
+8,406
| +30% | +$1.11M |
|
192
Linde
LIN
$226B
| $5.31M | 0.05% |
+20,149
| New | +$4.95M |
|
193
Zscaler
ZS
$27.3B
| $5.21M | 0.05% |
26,098
-10,677
| -29% | -$1.7M |
|
194
PayPal
PYPL
$50.5B
| $5.15M | 0.04% |
+21,990
| New | +$4.56M |
|
|
MZTI
195
The Marzetti Company
MZTI
$3.11B
| $5.14M | 0.04% |
27,984
+14,588
| +109% | +$2.54M |
|
196
Universal Health Services
UHS
$10.5B
| $5.13M | 0.04% |
37,342
+18,164
| +95% | +$2.26M |
|
197
Vulcan Materials
VMC
$36.9B
| $5.12M | 0.04% |
34,540
-19,403
| -36% | -$2.77M |
|
198
Grand Canyon Education
LOPE
$3.98B
| $5.07M | 0.04% |
54,419
+32,996
| +154% | +$2.82M |
|
199
T. Rowe Price
TROW
$24.3B
| $4.97M | 0.04% |
+32,837
| New | +$4.7M |
|
200
Chemed
CHE
$7.22B
| $4.87M | 0.04% |
9,136
+5,136
| +128% | +$2.52M |
|
Similar funds
Ray Dalio's Q4 2020 Portfolio in Review
As of Q4 2020, Ray Dalio held 599 positions worth $11.6B, up 39% from $8.31B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ray Dalio deployed $2.24B of net new capital in Q4 2020, opening 169 new positions and adding to 233 existing holdings. Its largest new stake was JPMorgan Chase: 412,755 shares worth $52.4M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $436M trimmed.
- Ray Dalio's largest Q4 2020 buy was JPMorgan Chase: 412,755 shares worth $52.4M.
- Ray Dalio added most to Walmart Inc in Q4 2020, an estimated $245M increase.
- Ray Dalio's biggest Q4 2020 reduction was SPDR Gold Trust, cutting an estimated $436M.
- Ray Dalio fully exited Tesla in Q4 2020, selling an estimated $15.3M.
- Ray Dalio's ten largest holdings make up 43% of its $11.6B portfolio in Q4 2020.
- Ray Dalio opened 169 new positions and closed 74 in Q4 2020.
- Ray Dalio's portfolio value rose 39% quarter-over-quarter to $11.6B.
Based on Bridgewater Associates's 13F filing for Q4 2020, filed 12 Feb 2021.